United States · FDA National Drug Code directory
SERTRALINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-651_a189f92d-a14a-45be-8f55-4b81fe2dce92
- Product NDC
- 71610-651
- Form
- TABLET, FILM COATED
- Composition / generic term
- SERTRALINE HYDROCHLORIDE
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170209
- Source listing expiry
- 20261231
Source-listed ingredients
- SERTRALINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET, FILM COATED in 1 BOTTLE (71610-651-15) · 71610-651-15
- 30 TABLET, FILM COATED in 1 BOTTLE (71610-651-30) · 71610-651-30
- 45 TABLET, FILM COATED in 1 BOTTLE (71610-651-45) · 71610-651-45
- 60 TABLET, FILM COATED in 1 BOTTLE (71610-651-53) · 71610-651-53
- 90 TABLET, FILM COATED in 1 BOTTLE (71610-651-60) · 71610-651-60
- 135 TABLET, FILM COATED in 1 BOTTLE (71610-651-73) · 71610-651-73
- 180 TABLET, FILM COATED in 1 BOTTLE (71610-651-80) · 71610-651-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →